欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0886/001
药品名称Emla 25 mg/g + 25 mg/g
活性成分
    • lidocaine 25.0 mg/g
    • prilocaine 25.0 mg/g
剂型Cream
上市许可持有人Aspen Pharma Trading Limited 3016 Lake Drive Citywest Business Campus Dublin 24 Ireland
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
    • Cyprus (CY)
    • Malta (MT)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
许可日期2015/03/18
最近更新日期2024/05/03
药物ATC编码
    • N01BB20 combinations
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase